Precision treatment of Singleton Merten syndrome with ruxolitinib: a case report.

Philip J BroserUrsula von MengershausenKatrin HeldtDeborah BartholdiDominique BraunChristine WolfMin Ae Lee-Kirsch

Published in: Pediatric rheumatology online journal (2022)

JAK inhibition represents a valuable therapeutic option for patients with SGMRT1. Our findings also highlight the potential of a patient-tailored therapeutic approach based on pathogenetic insight.

Keyphrases

case report
preterm birth
smoking cessation
risk assessment
birth weight
climate change
replacement therapy